Pasi Joutjärvi

Oma itseni.

[Nexstim @NexstimOyj]

Finnish Private Clinic Group Orders Additional Nexstim NBS 6 System: https://t.co/rWJdj2nDYI

[Nexstim @NexstimOyj]

Delve Psychiatry Upgrades to Nexstim's Latest NBS 6 Platform: https://t.co/13MhqgozkI

[Nexstim @NexstimOyj]

Nexstim Receives NBS 6 Therapy System Order from a Neurology Clinic in the United States: https://t.co/R5oKBfQtPf

[Pasi Joutjärvi @PJoutjarvi]

@NexstimOyj No nyt 🙏

[Nexstim @NexstimOyj]

Nexstim Receives a New Order for Ten NBS 6 Systems from Distributor: https://t.co/UuYodbHQFL

[Nexstim @NexstimOyj]

Nexstim Receives Expanded Health Canada Approval for NBS 6 Diagnostics and Pain Applications: https://t.co/jZsno3HYSm

[Nexstim @NexstimOyj]

Nexstim Secures First NBS 6 Sale Following Malaysian Market Authorization: https://t.co/wFTqw9hdux

[Nexstim @NexstimOyj]

Nexstim Receives Malaysian Authorization for Commercial Distribution of NBS System 6: https://t.co/TVq6zAnkGE

[Nexstim @NexstimOyj]

Nexstim Receives NBS 6 Therapy System Order from New Customer in the United States: https://t.co/ICKQstgAWz

[Nexstim @NexstimOyj]

Nexstim Receives Order for Ten NBS 6 Systems from Distributor: https://t.co/keTgePLpRn

[Pasi Joutjärvi @PJoutjarvi]

Unlock up to 10,020 USDT in New User Bonuses https://t.co/sU9O2PTq1M

[Pasi Joutjärvi @PJoutjarvi]

NFE gets strong support for $5.8 billion restructuring plan https://t.co/khSNeaHfjp käyttäen @LNG Prime

[Nexstim @NexstimOyj]

Nexstim announces the launch of the NBS 6 system for the treatment of Major Depressive Disorder (MDD) in adolescent patients, 15 to 21 years of age, in the United States.
See press release: https://t.co/ryVmarZamy

[Nexstim @NexstimOyj]

Nexstim announces the launch of the NBS 6 system for the treatment of Obsessive Compulsive Disorder (OCD) in the United States. See press release: https://t.co/S1WP2Gz9XD

[Nexstim @NexstimOyj]

Nexstim has received an order for an NBS 6 from a Finnish university hospital. See the full press release here: https://t.co/qBlySnNFgJ

[Nexstim @NexstimOyj]

Following the release of its H2 and FY2025 financial results, Nexstim Plc will organize two webinars on Thursday February 26.

Visit webinar pages for details:
Webinar in Finnish / webinaari suomeksi: https://t.co/mGUOqmtvKo
Webinar in English: https://t.co/xd4LwK7A3D

[Nexstim @NexstimOyj]

Nexstim has received certification for the use of its NBS 6 product for post-operative rehabilitation under MDR (Regulation (EU) 2017/745) in the EU.
See press release on our website: https://t.co/UNFfopzXK0